|
Market Closed -
Canadian Securities Exchange
15:59:59 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.4700 CAD | -6.00% |
|
+2.17% | -32.86% |
| 10-21 | Grown Rogue International Increases Ownership Interest in New Jersey Subsidiary to 70% | MT |
| 10-19 | Grown Rogue International Inc. acquired an additional 26% stake in ABCO Garden State, LLC. | CI |
| Market Cap | 83.33M 74.74M 68.3M 62.35M 117M 7.83B 121M 823M 328M 4.18B 313M 306M 13.19B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 98.63M 88.46M 80.84M 73.8M 139M 9.27B 143M 974M 389M 4.95B 370M 362M 15.62B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript: Grown Rogue International Inc.
| 1 day | -6.00% | ||
| 1 week | +2.17% | ||
| Current month | +2.17% | ||
| 1 month | -17.54% | ||
| 3 months | -21.67% | ||
| 6 months | -4.08% | ||
| Current year | -32.86% |
| 1 week | 0.47 |  | 0.57 |
| 1 month | 0.46 | | 0.59 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.32 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 2018-11-14 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 2016-09-30 |
| Director of Finance/CFO | 42 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 2018-11-14 |
J. Strickler
CHM | Chairman | 45 | - |
Ryan Kee
BRD | Director/Board Member | 42 | 2024-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/21/26 | Option | Director | 120,000 | 0.0480% | ||
| 7/21/26 | Option | Director | 120,000 | 0.0480% | ||
| 7/21/26 | Free | Founder | 1,000,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.00% | +2.17% | -4.08% | +20.51% | 83.33M | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,206B | |
| +1.43% | +1.11% | +48.05% | +83.05% | 665B | |
| +1.07% | -1.21% | +32.92% | +104.92% | 515B | |
| -0.36% | -3.25% | +45.42% | +65.10% | 381B | |
| -0.14% | -1.87% | +70.06% | +41.09% | 362B | |
| -0.78% | -0.52% | +30.47% | +58.09% | 307B | |
| -0.80% | -0.21% | +7.98% | +36.17% | 289B | |
| +0.03% | -1.20% | +43.79% | +69.83% | 249B | |
| -0.41% | -2.22% | +40.43% | +107.03% | 207B | |
| Average | -0.68% | -1.17% | +36.15% | +71.15% | 417.98B | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.71% | +88.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 24.23M 22.15M 20.22M 38.09M 2.54B 39.29M 267M 106M 1.36B 101M 99.23M 4.28B | 32.43M 29.08M 26.58M 24.26M 45.72M 3.05B 47.16M 320M 128M 1.63B 122M 119M 5.13B |
| Net income | -11.3M -10.14M -9.27M -8.46M -15.94M -1.06B -16.44M -112M -44.53M -567M -42.43M -41.52M -1.79B | 1.73M 1.55M 1.42M 1.29M 2.44M 163M 2.52M 17.09M 6.81M 86.76M 6.49M 6.35M 274M |
| Net Debt | 3.7M 3.32M 3.04M 2.77M 5.22M 348M 5.39M 36.6M 14.59M 186M 13.9M 13.61M 587M | 15.3M 13.72M 12.54M 11.45M 21.57M 1.44B 22.25M 151M 60.28M 767M 57.43M 56.19M 2.42B |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | $0.4700 | -6.00% | 19,000 |
| 26-11-05 | $0.5000 | -1.96% | 47,603 |
| 26-11-04 | $0.5100 | 0.00% | 4,472 |
| 26-11-03 | $0.5100 | 0.00% | 13,000 |
| 26-11-02 | $0.5100 | +10.87% | 154,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
